VA
VMD icon

Verdad Advisers’s Viemed Healthcare VMD Stock Holding History

Verdad Advisers’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
+52,879
New +$524K 0.58% 62

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Verdad Advisers's VMD Position: Q2 2026 in Review

Verdad Advisers opened a new position in Viemed Healthcare (VMD) in Q2 2026: 52,879 shares worth $603K. The stake represents 0.58% of the portfolio and ranks #62 among its holdings.

166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Verdad Advisers held 52,879 shares of Viemed Healthcare worth $603K as of Q2 2026.
  • Viemed Healthcare was a new Verdad Advisers position in Q2 2026.
  • Viemed Healthcare made up 0.58% of Verdad Advisers's portfolio in Q2 2026, its #62 holding.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.